Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25051525 | 0.98 | ALOX5 (0.35) | ALOX5MAPTKDM4ETSHRLMNA | |
| SCHEMBL23203889 | 0.97 | ALOX5 (0.35) | ALOX5MAPTKDM4ETSHRLMNA | |
| SCHEMBL25051526 | 0.96 | ALOX5 (0.33) | ALOX5PIK3CDPIK3CBPRKDC | |
| SCHEMBL23738275 | 0.95 | ALOX5 (0.35) | ALOX5PIK3CDPIK3CBPRKDC | |
| SCHEMBL23737345 | 0.94 | ALOX5 (0.35) | ALOX5PIK3CDPIK3CBPRKDC | |
| SCHEMBL23738779 | 0.94 | ALOX5 (0.34) | ALOX5MAPTKDM4ETSHRLMNA | |
| SCHEMBL24383201 | 0.93 | TSHR (0.32) | MAPTKDM4ETSHRMAPK1HSD17B10 | |
| SCHEMBL23737349 | 0.93 | ALOX5 (0.33) | ALOX5MAPTKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL23737530 | 0.93 | ALOX5 (0.33) | ALOX5PIK3CDPIK3CBPRKDC | |
| SCHEMBL23204080 | 0.92 | KDM4E (0.33) | MAPTKDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230049674-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-02-16 | — | — | US | disclosed |
| EP-3863077-B1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2022-05-04 | — | — | EP | disclosed |
| EP-3863077-A1 | ORGANIC LIGHT EMITTING DIODE | LG Chem, Ltd. (KR) | 2021-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230049674-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, ELOVL1, CRY1 | ALOX5 642/4885MAPT 1921/4885KDM4E 2327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.